Form 4: Haemonetics Director Michael J. Coyle Reports Acquisition of Restricted Stock Units

Director Michael J. Coyle reports acquisition of 2,207 restricted stock units (RSUs) of Haemonetics Corp.

Summary

• On July 25, 2024, Michael J. Coyle, a director of Haemonetics Corp, reported the acquisition of 2,207 restricted stock units (RSUs).
• These RSUs were granted under the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan.
• The RSUs vest 100% on the first anniversary of the grant date.
• Each RSU represents a contingent right to receive one share of Haemonetics Corp's common stock when vested.
• Following the transaction, Coyle directly owns 12,701 shares of Haemonetics Corp common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of RSUs by a director is generally seen as a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest 100% on the first anniversary of the grant date, indicating a future event where Coyle may receive shares of common stock.

Industry Context

This is a standard Form 4 filing, reflecting a common practice of granting stock-based compensation to company directors. It's typical for companies to use RSUs as part of their long-term incentive plans to align the interests of management with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation for directors is a common practice across publicly traded companies.
• The vesting schedule of 100% on the first anniversary is fairly standard, aligning with typical industry practices for RSU grants.
• Companies like Medtronic, Boston Scientific, and Abbott also utilize stock-based compensation as part of their executive and director compensation packages.

Stakeholder Impact

• The acquisition of RSUs by a director can have a slightly positive impact on shareholder sentiment.

Key Dates